"Renown Institute for Neurosciences offers specialists who care for the most complex brain and nerve neurological cases using the latest treatment methods. From muscle pain and migraines to neuropathy and stroke, our team has the experience to treat even the most challenging neurological conditions using the most effective tools and techniques available."

During the past decade, Renown Institute for Neurosciences conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renown Institute for Neurosciences" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Renown Institute for Neurosciences" are "Migraine Disorders" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Partial Onset Seizures" (1 trials), "Secondary Prevention" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Renown Institute for Neurosciences" in a lesser frequency.

Most popular intervention types in "Renown Institute for Neurosciences" are "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "onabotulinumtoxinA" (2 trials), "ASA 100 mg" (1 trials), "Investigational new drug, company code: BGG492" (1 trials), "Placebo" (1 trials) and "Topiramate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Renown Institute for Neurosciences" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Renown Institute for Neurosciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Renown Institute for Neurosciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Renown Institute for Neurosciences, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".